Industry News
Combination therapy for HIV
Merck drug raltegravir shows good results as part of combination therapy [ + ]
Cash for medical research support
The NHMRC has announced $29 million for medical research institute support services [ + ]
Opinion: Cash, not coddling, needed from Carr
The biotechnology sector in Australia is fuming at the Federal Government, according to the editorial in the latest issue of ALS [ + ]
Keep it on, HIV+ people warned
Australian researchers urge HIV-positive people on antiretrovirals to continue practising safe sex [ + ]
Twin lasers improve precision measurement
The twin laser technology, developed by physicists from ANU and Laboratoire Kastler Brossel in Paris in the laboratories of the Australian Research Council Centre of Excellence for Quantum-Atom Optics at ANU, may dramatically improve precision measurement ranging from atomic to outer-space applications.
[ + ]Suspect protein promotes DNA repair
Caution against targeting HMGB1 protein in inflammation drug development [ + ]
Flu's up for Rockeby
Rockeby receives $252,000 worth of orders for bird flu test [ + ]
Eye and ear on bionics
Centre for bionics for NSW, international conference for Victoria [ + ]
More for AtCor
AtCor wins two more supply contracts for SphygmoCor, worth $1.66M [ + ]
GTG responds to BRCA row
Genetic Technologies responds to criticism over patent enforcement decision [ + ]
Freeze my puppies
Genetic Technologies acquires Frozen Puppies Dot Com [ + ]
Anadis begins trials for IBD
Israeli trial due for completion in 2009, commercialisation as nutritional to follow [ + ]
Progen abandons PI-88
Massive share price plunge as Progen abandons lead compound trial [ + ]
Pfizer Fellowships close soon
Applications for the Pfizer Australia Research Fellowships close on Monday [ + ]
Biotech summit approaches
The annual Australian Biotechnology Summit begins next week [ + ]
